Skip to Content
🌐Ship toSelect country

Teosyal RHA Kiss Lidocaine - 2 x 0,7ml

Teosyal RHA Kiss is Teoxane's dedicated lip filler within the RHA range, formulated at 23mg/ml cross-linked HA with 0.3% lidocaine, based on the RHA 2 specification but tailored to lip volume, contour and perioral line correction. Its Resilient Hyaluronic Acid technology allows the gel to adapt to lip movement for natural, dynamic results, with reported duration of roughly 6-9 months. For use by licensed, trained medical professionals only.

106.00 € 106.00 €
  • Brand
Terms and Conditions

Shipping: 
DHL EXPRESS SHIPPING (EU) — approx. 2-3 working days
STANDARD SHIPPING (EU) — approx. 7-10 working days
Select your delivery country in the header to check availability for your destination.
Category Fillers Brand Teosyal®
SKU A5516 Share
Treatment Areas Lips
Tags Cross-Linked Hyaluronic AcidLidocaine

Teosyal RHA Kiss is Teoxane's lip-specific formulation within the RHA range, designed to add natural-looking volume and shape to the lips while preserving natural movement thanks to the RHA technology. Formulated with lidocaine for a more comfortable injection experience.

CONCENTRATION

  • RHA-technology hyaluronic acid
  • Lidocaine hydrochloride 0.3%

THE PACK INCLUDES

  • 2 x 0.7ml Syringes

STORAGE CONDITIONS

  • Store between 2°C and 25°C
  • Protect from direct sunlight

RESULTS & DURATION

Results typically last 6-9 months, depending on individual metabolism.

INDICATIONS

  • Lip volume loss
  • Lip shape and definition

TREATMENT AREAS

  • Lips
  • Mouth

Teosyal RHA Kiss is injected into the lip tissue using linear threading or micro-bolus technique.

Results are visible immediately, with final results assessed after 1-2 weeks once any swelling has resolved.

  • Pregnancy or breastfeeding
  • People under the age of 18
  • Active infection or inflammation at the treatment site
  • Known hypersensitivity to hyaluronic acid or lidocaine
  • Patients prone to hypertrophic scarring
  • Autoimmune diseases affecting the skin
  • Active infection or cold sores in the treatment area